Skip to Content
Merck
CN
  • [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].

[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine (2013-10-31)
Masami Tanaka, Keiko Tanaka
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
FTY720, ≥98% (HPLC)